Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
STMC-103H
BIOLOGICAL
2 trials
Sponsors
Siolta Therapeutics, Inc.
Conditions
Atopic Dermatitis
Atopic Immunoglobulin E-Mediated Allergic Disorder
Type 1 Hypersensitivity
Phase 1
A Phase 1b Study of STMC-103H in Multi-Sensitized Allergic Subjects Who Are Otherwise Healthy
NCT03819881
Siolta Therapeutics, Inc.
Atopic Immunoglobulin E-Mediated Allergic Disorder
Start: 2018-10-10
End: 2019-11-30
Target: 60
Updated: 2019-01-29
Allergic Disease Onset Prevention Study
Completed
NCT05003804
Siolta Therapeutics, Inc.
Atopic Dermatitis, Type 1 Hypersensitivity
Start: 2021-09-01
End: 2025-10-21
Updated: 2025-11-20